|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/135 | |
| A61K 47/26 | |||
| A61P 25/16 |
| (11) | Number of the document | 1827409 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05851829.1 |
| Date of filing the European patent application | 2005-11-17 | |
| (97) | Date of publication of the European application | 2007-09-05 |
| (45) | Date of publication and mention of the grant of the patent | 2011-08-24 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2005/041882 |
| Date | 2005-11-17 |
| (87) | Number | WO 2006/057912 |
| Date | 2006-06-01 |
| (30) | Number | Date | Country code |
| 630918 P | 2004-11-24 | US | |
| 997785 | 2004-11-24 | US |
| (72) |
PATASHNIK, Shulamit, IL
LICHT, Daniella, IL
GILBERT, Adrian, IL
|
| (73) |
TEVA PHARMACEUTICAL INDUSTRIES, LTD.,
5 Basel Street, P.O. Box 3190, 49131 Petach-Tikva,
IL
|
| (54) | RASAGILINE ORALLY DISINTEGRATING COMPOSITIONS |
| RASAGILINE ORALLY DISINTEGRATING COMPOSITIONS |